Portal de Periódicos da CAPES

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

2013; Elsevier BV; Volume: 15; Issue: 4 Linguagem: Inglês

10.1016/j.jmoldx.2013.03.001

1943-7811

Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Dhananjay Chitale, Sanja Đačić, Giuseppe Giaccone, Robert B. Jenkins, David J. Kwiatkowski, Juan‐Sebastian Saldivar, Jeremy A. Squire, Erik Thunnissen, Marc Ladanyi,

Lung Cancer Research Studies

To establish evidence-based recommendations for the molecular analysis of lung cancers that are required to guide EGFR- and ALK-directed therapies, addressing which patients and samples should be tested, and when and how testing should be performed.